Pro 2013-002 (Announcement of Jianfeng Group on the Issuance of Corporate Bonds)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Lin 2013-002
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Issuing Corporate Bonds
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Important Note: The Company intends to issue corporate bonds with a total amount of not more than 0.6 billion yuan and a maturity of not more than 7 years. will be used to repay some of the company's debts and to supplement the company's working capital .
Resolutions of the 1. Board of Directors
On December 31, 2012, the company held the 8th meeting of the 8th Board of Directors of Zhejiang Jianfeng Group Co., Ltd. by means of communication. The company currently has nine directors, and nine directors participating in the voting , comply with the provisions of the "Company Law" and the "Articles of Association", and the resolutions made are legal and valid. The meeting considered and proposal on the issuance of corporate bonds. after voting on the proposal in items, passed . the result of voting was all 9 votes for , 0 votes against , 0 abstentions. The specific contents of the
2. plan
1 and the issuance scale
The total face value of the corporate bonds issued this time shall not exceed .3 billion yuan (including .5 billion yuan). The specific issuance scale shall be submitted to the shareholders' general meeting to authorize the board of directors to determine within the above-mentioned scope.
2 , Placing Arrangement to Original Shareholders of the Company
This public offering of corporate bonds can be placed to shareholders of the Company. The specific placing arrangement ( includes whether to place, placing proportion, etc. ) is submitted to the shareholders' general meeting to authorize the board of directors to determine according to the market conditions at the time of issuance and the specific matters of issuance, and disclose it in the bond prospectus.
3 , Bond Term
The term of the corporate bonds issued this time is not more than 7 years, which can be a single term variety or a mixed variety of maturities, the specific term composition of the corporate bonds issued and the issuance scale of each term variety shall be submitted to the general meeting of shareholders to authorize the board of directors to determine in accordance with relevant regulations and market conditions before issuance.
4 , Bond Interest Rate and Determination Method
The current bond is a fixed-rate bond. The coupon rate of the current bond will be determined by the issuer and the sponsor (lead underwriter) according to the results of the offline inquiry in accordance with the relevant provisions of the state and after being filed by the regulatory authorities. The coupon rate of the bond is simple interest on an annual basis, without compound interest.
5 , Issuance Method
After the issuance is approved, the corporate bonds can be issued at one time or in installments. The specific issuance method is submitted to the general meeting of shareholders to authorize the board of directors to determine according to market conditions and the company's capital needs.
6 , Issuing Object
This corporate bond is issued to all investors, and investors subscribe in cash.
7 , Guarantee Arrangement
Whether this bond issue adopts guarantee and the specific guarantee method authorizes the board of directors to determine according to relevant regulations and market conditions.
8 , Use of Raised Funds
The raised funds of this issuance of corporate bonds are intended to be used to repay part of the company's debts , to supplement the company's working capital, optimize the company's debt structure , improve the company's capital situation. The general meeting of shareholders of the company is requested to authorize the board of directors to decide on the amount and proportion of the raised funds to repay the company's debts and supplement the working capital according to the actual situation of the company's financial situation.
9 , issuance of bonds listed
on the premise of meeting the listing conditions, the company will submit an application for listing and trading of this corporate bond to the Shanghai Stock Exchange as soon as possible after the issuance of this corporate bond.
10 , the validity period of the resolution
The validity period of the resolution on the issuance of corporate bonds is 24 months from the date of approval at this shareholders' meeting.
3. The above proposals still need to be submitted to the general meeting of shareholders for deliberation and submitted to the China Securities Regulatory Commission for approval before implementation .
hereby announce
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
December 31, 2012
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page